Cargando…
Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report
Subcutaneous fat necrosis of the newborn (SCFN) is a panniculitis that develops in fatty areas after fetal or perinatal distress. Prognosis is generally good with complete regression, but it can be complicated by metabolic abnormalities like hypoglycemia, hypertriglyceridemia, thrombocytopenia, and...
Autores principales: | Martinelli, Stefano, Pitea, Marco, Gatelli, Italo Francesco, Raouf, Tara, Barera, Graziano, Vitelli, Ottavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096199/ https://www.ncbi.nlm.nih.gov/pubmed/35573963 http://dx.doi.org/10.3389/fped.2022.845424 |
Ejemplares similares
-
Neonatal Hypercalcemia Secondary to Subcutaneous Fat Necrosis Successfully Treated with Pamidronate: A Case Series and Literature Review
por: Samedi, Veronica Mugarab, et al.
Publicado: (2014) -
Neonatal subcutaneous fat necrosis with hypercalcemia treatment using calcitonin
por: Alsofyani, Khouloud A.
Publicado: (2018) -
Pamidronate therapy for hypercalcemia of childhood malignancy
por: Sng, Andrew, et al.
Publicado: (2015) -
Pamidronate “zebra lines”: A treatment timeline
por: Loizidou, Avgi, et al.
Publicado: (2017) -
Subcutaneous Fat Necrosis and Hypercalcemia with Nephrocalcinosis in Infancy: Case Report and Review of the Literature
por: Chrysaidou, Katerina, et al.
Publicado: (2021)